- Home
- SFM vs QGEN Comparison
SFM vs QGEN Comparison
Compare SFM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFM | QGEN |
|---|---|---|
| Founded | 2002 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 10.7B |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SFM | QGEN |
|---|---|---|
| Price | $84.32 | $47.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $138.64 | $50.68 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | 49.03 | ★ 331.20 |
| EPS | ★ 5.15 | 1.84 |
| Revenue | ★ $8,653,696,000.00 | $2,070,781,000.00 |
| Revenue This Year | $15.50 | $7.37 |
| Revenue Next Year | $10.24 | $5.65 |
| P/E Ratio | ★ $16.28 | $26.16 |
| Revenue Growth | ★ 16.60 | 5.32 |
| 52 Week Low | $75.75 | $37.63 |
| 52 Week High | $182.00 | $51.88 |
Technical Indicators
Market Signals| Indicator | SFM | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | 60.62 |
| Support Level | $78.45 | $43.59 |
| Resistance Level | $82.87 | $48.69 |
| Average True Range (ATR) | 2.47 | 0.73 |
| MACD | 1.53 | 0.51 |
| Stochastic Oscillator | 89.79 | 83.08 |
Price Performance
Historical ComparisonAbout SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).